Theralymph : An innovative therapy for lymphedema

THERALYMPH

OUR MAIN OBJECTIVES

Describe the physiopathology of lymphedema to better understand mechanisms of loss of lymphatic function.

Identify therapeutic targets for lymphedema to restore the lymphatic flow.

Validate therapeutic targets in preclinic models of lymphedema.

Perform a Phase I/IIa gene therapy clinical trial on patients who developed lymphedema after breast cancer using lentiflash vectors.

Workpackages

Partners

Months

NEws

Follow Along

Post-doctoral position at I2MC-Toulouse (France)

Post-doctoral position at I2MC-Toulouse (France)

Post-doctoral position at I2MC-Toulouse (France) : Theralymph : An innovative therapy for lymphedema A postdoctoral position, with salary funded for three years is available in the team “Molecular regulations of (lymph)angiogenic growth factors in vascular diseases”...

Theralymph Events